Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
1 clinical trials · Sponsor
◉ Watch Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia (NCT06603142) | Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd | 2024-04-22 |
Track Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.